Tella Inc 2191.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 1:27 PM JST
255.00quote price arrow down-5.00 (-1.92%)
Volume
403,300
52 week range
92.00 - 2,175.00

...

Loading . . .

KEY STATS

  • Open256.00
  • Day High257.00
  • Day Low245.00
  • Prev Close260.00
  • 52 Week High2,175.00
  • 52 Week High Date06/09/20
  • 52 Week Low92.00
  • 52 Week Low Date03/13/20
  • Market Cap65.47M
  • Shares Out25.33M
  • 10 Day Average Volume450,755.56
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change84.78

RATIOS/PROFITABILITY

  • EPS (TTM)-19.70
  • P/E (TTM)-12.94
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Tella Inc News

There is no recent news for this security.

Latest 2191.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
tella, Inc. is a Japan-based company mainly engaged in the provision of techniques and operational knowhow associated with cell medicines, as well as the research and development of regenerative medicine and cell medicine. The Company operates through three business segments. The Cell Medicine segment is engaged in the provision of cancer treatment technology and operational method centered on dendritic cell vaccine therapy. This segment is also engaged in the provision of...
Tomoyuki Taira
President
Address
17F, Ark Mori Bldg., 1-12-32, Akasaka
Shinjuku-ku, TKY
160-0023
Japan